Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Normative data for the EORTC QLQ-C30 from the Austrian general population.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • Corporate Authors:
    • المصدر:
      Publisher: BioMed Central Country of Publication: England NLM ID: 101153626 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-7525 (Electronic) Linking ISSN: 14777525 NLM ISO Abbreviation: Health Qual Life Outcomes Subsets: MEDLINE
    • بيانات النشر:
      Original Publication: [London] : BioMed Central, c2003-
    • الموضوع:
    • نبذة مختصرة :
      Background: The European Organisation for Research and Treatment of Cancer (EORTC) QLQ-C30 is a widely used cancer-specific questionnaire assessing 15 domains of health-related quality of life (HRQoL). Our aim was to facilitate the interpretation of scores on this questionnaire by providing Austrian normative data based on a general population sample.
      Methods: The calculation of normative data was based on the EORTC QLQ-C30 data collected from an Austrian general population sample that was part of an international online panel study on the development of European normative data. Data reported herein were stratified and weighted by age and sex. Normative data were calculated for all 15 HRQoL domains of the EORTC QLQ-C30. For precise predictions of EORTC QLQ-C30 scores, a regression model based on sex, age and the presence of health conditions was built.
      Results: The Austrian sample comprised 1002 Austrian participants (50.1% female, 51.4% when weighted by age and sex based on United Nation statistics). The mean age was 53.7 years (weighted: 47.7 years) and 53.6% (weighted: 47.4%) reported at least one health condition. Men reported better physical (Cohen's d = 0.17) and emotional (Cohen's d = 0.17) functioning as well as less fatigue (Cohen's d = 0.18) and insomnia (Cohen's d = 0.25) compared with women. Younger individuals (< 40 years) reported less dyspnea (Cohen's d = 0.61) and pain (Cohen's d = 0.51), whereas older individuals (≥60 years) reported better emotional functioning (Cohen's d = 0.55).
      Conclusions: We present Austrian normative data for the EORTC QLQ-C30. Differences by age and sex are mostly in line with the findings of other European normative studies. The Austrian population sample shows higher HRQoL and lower morbidity compared with other European countries. The normative data in this study will facilitate the interpretation of EORTC QLQ-C30 scores in oncological practice and research at a national and international level (including cross-cultural comparisons).
    • References:
      Eur J Cancer. 2015 Dec;51(18):2808-19. (PMID: 26602015)
      Eur J Cancer. 2001 Jul;37(11):1345-51. (PMID: 11435063)
      Ann Oncol. 2015 Sep;26(9):1846-1858. (PMID: 25888610)
      Eur J Cancer. 2019 Jan;107:153-163. (PMID: 30576971)
      Acta Oncol. 2012 Jan;51(1):10-6. (PMID: 21961499)
      J Natl Cancer Inst. 1993 Mar 3;85(5):365-76. (PMID: 8433390)
      Eur J Cancer. 1998 Aug;34(9):1381-9. (PMID: 9849421)
      Qual Life Res. 2009 Jun;18(5):547-55. (PMID: 19337852)
      Radiol Oncol. 2017 Apr 22;51(3):342-350. (PMID: 28959171)
      Health Qual Life Outcomes. 2016 Jun 07;14:87. (PMID: 27267486)
      Eur J Cancer. 2001 Jul;37(11):1331-4. (PMID: 11435060)
      Qual Life Res. 2014 Apr;23(3):971-6. (PMID: 24097080)
      Eur J Cancer. 2019 Jan;107:133-141. (PMID: 30576969)
      Value Health. 2020 May;23(5):666-673. (PMID: 32389233)
      Qual Life Res. 2016 Mar;25(3):595-604. (PMID: 26353905)
      Clin Endocrinol (Oxf). 2011 Oct;75(4):544-54. (PMID: 21615448)
      Acta Oncol. 2014 Jul;53(7):958-65. (PMID: 24456505)
      Qual Life Res. 2014 Oct;23(8):2183-93. (PMID: 24676897)
      BMJ Open. 2018 Jan 10;8(1):e019117. (PMID: 29326191)
      Eur J Health Econ. 2019 Mar;20(2):205-216. (PMID: 29445941)
      Acta Oncol. 2013 Feb;52(2):249-58. (PMID: 23181387)
      Patient Educ Couns. 2016 Dec;99(12):2012-2017. (PMID: 27506581)
      Eur J Cancer. 2016 Nov;68:73-81. (PMID: 27721057)
      Nat Rev Clin Oncol. 2017 Dec;14(12):763-772. (PMID: 28975931)
      J Clin Oncol. 2006 Jul 1;24(19):3178-86. (PMID: 16809741)
      J Clin Epidemiol. 2020 Feb;118:1-8. (PMID: 31639445)
      Surgery. 2018 Nov;164(5):986-992. (PMID: 30149935)
      Lancet Oncol. 2016 Jul;17(7):994-1003. (PMID: 27283863)
      Acta Oncol. 2018 Oct;57(10):1381-1391. (PMID: 29912607)
      Qual Life Res. 2019 Mar;28(3):621-627. (PMID: 30448911)
      Value Health. 2019 Feb;22(2):203-209. (PMID: 30711065)
      Qual Life Res. 2020 Feb;29(2):347-355. (PMID: 31606809)
    • Grant Information:
      001 2015 European Organisation for Research and Treatment of Cancer
    • Contributed Indexing:
      Keywords: Austria; EORTC QLQ-C30; General population; Normative data; Oncology; Patient-reported outcome measures; Quality of life
    • الموضوع:
      Date Created: 20200814 Date Completed: 20201111 Latest Revision: 20201111
    • الموضوع:
      20240628
    • الرقم المعرف:
      PMC7425034
    • الرقم المعرف:
      10.1186/s12955-020-01524-8
    • الرقم المعرف:
      32787854